These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3318448)

  • 1. Neuropharmacology of S-adenosyl-L-methionine.
    Baldessarini RJ
    Am J Med; 1987 Nov; 83(5A):95-103. PubMed ID: 3318448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects.
    Silveri MM; Parow AM; Villafuerte RA; Damico KE; Goren J; Stoll AL; Cohen BM; Renshaw PF
    Biol Psychiatry; 2003 Oct; 54(8):833-9. PubMed ID: 14550683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine.
    Fava M; Giannelli A; Rapisarda V; Patralia A; Guaraldi GP
    Psychiatry Res; 1995 Apr; 56(3):295-7. PubMed ID: 7568552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
    Chawla RK; Bonkovsky HL; Galambos JT
    Drugs; 1990; 40 Suppl 3():98-110. PubMed ID: 2081485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-adenosylmethionine and affective disorder.
    Carney MW; Toone BK; Reynolds EH
    Am J Med; 1987 Nov; 83(5A):104-6. PubMed ID: 3318437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L-methionine in rats.
    Fernández E; Galán AI; Morán D; González-Buitrago JM; Muñoz ME; Jiménez R
    J Pharmacol Exp Ther; 1995 Oct; 275(1):442-9. PubMed ID: 7562583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.
    Friedel HA; Goa KL; Benfield P
    Drugs; 1989 Sep; 38(3):389-416. PubMed ID: 2680435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropharmacology of S-adenosyl methionine.
    Carney MW
    Clin Neuropharmacol; 1986; 9(3):235-43. PubMed ID: 2424592
    [No Abstract]   [Full Text] [Related]  

  • 9. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Psychopharmacol Bull; 1988; 24(1):189-94. PubMed ID: 3387521
    [No Abstract]   [Full Text] [Related]  

  • 10. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.
    Hardy ML; Coulter I; Morton SC; Favreau J; Venuturupalli S; Chiappelli F; Rossi F; Orshansky G; Jungvig LK; Roth EA; Suttorp MJ; Shekelle P
    Evid Rep Technol Assess (Summ); 2003 Aug; (64):1-3. PubMed ID: 12899148
    [No Abstract]   [Full Text] [Related]  

  • 11. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.
    Bottiglieri T
    Am J Clin Nutr; 2002 Nov; 76(5):1151S-7S. PubMed ID: 12418493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-L-methionine.
    Rafique S; Guardascione M; Osman E; Burroughs AK; Owen JS
    Clin Sci (Lond); 1992 Sep; 83(3):353-6. PubMed ID: 1327655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of phospholipids in microsomes of the rat aorta.
    Jaiswal RK; Landon EJ; Sastry BV
    Biochim Biophys Acta; 1983 Nov; 735(3):367-79. PubMed ID: 6639945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.
    Kaye GL; Blake JC; Burroughs AK
    Drugs; 1990; 40 Suppl 3():124-8. PubMed ID: 2081477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.
    Salmaggi P; Bressa GM; Nicchia G; Coniglio M; La Greca P; Le Grazie C
    Psychother Psychosom; 1993; 59(1):34-40. PubMed ID: 8441793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosyl-L-methionine modulates Na+ + K+-ATPase activity in rat colonic basolateral membranes.
    Brown MD; Dudeja PK; Brasitus TA
    Biochem J; 1988 Apr; 251(1):215-22. PubMed ID: 2839160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.
    Mischoulon D; Fava M
    Am J Clin Nutr; 2002 Nov; 76(5):1158S-61S. PubMed ID: 12420702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosylmethionine levels in psychiatric and neurological disorders: a review.
    Bottiglieri T; Hyland K
    Acta Neurol Scand Suppl; 1994; 154():19-26. PubMed ID: 7524260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the dietary supplement S-adenosyl-L-methionine.
    Fetrow CW; Avila JR
    Ann Pharmacother; 2001 Nov; 35(11):1414-25. PubMed ID: 11724095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.